Neuroinflammation in Parkinson disease


   ►  The conference is postponed 


On Friday, March 13, 2020, the CRCHUM Conferences will host Etienne Hirsch, Director of INSERM and Aviesan national institute of Neurosciences, Cognitive sciences, Neurology and Psychiatry, and Team leader, Experimental therapeutics of parkinson disease at the Brain and spine institute.
 

Abstract

Both epidemiological and genetic studies support a role of neuroinflammation in the pathophysiology of Parkinson disease. Furthermore, combination of post mortem studies and experimental analyses suggest the involvement of innate as well as adaptive immunity in the degenerative process. Yet, anti-inflammatory strategies are not successful in mitigating neuronal degeneration in Parkinson disease. In this seminar, I will review unanswered questions related to neuroinflammatory processes in Parkinson disease that might stimulate research in the field and lead to clinical developments for neuroprotection based on anti-inflammatory strategies.

Invited by Diana Matheoud. Neuroscience theme.

This conference will be presented in English.
 

Friday, March 13, at 12
Auditorium of the CRCHUM , R05.210 and R05.220
900 Saint-Denis Street, 5th floor 
Montreal (Quebec), H2X 0A9

Etienne Hirsch, Ph.D.
Director of INSERM and Aviesan national institute of neurosciences, Cognitive sciences, Neurology and psychiatry, France
Team leader, Experimental therapeutics of parkinson disease at the brain and spine institute, Hôpital Pitié Salpêtrière, Paris, France
 

About CRCHUM Conferences

The CRCHUM Conferences are free weekly meetings featuring renowned scientific speakers from various disciplines. These conferences are accredited by the Royal College of Physicians and Surgeons of Canada as continuing professional development activities.

About our scientific activities

> Schedule of the CRCHUM Conferences and the scientific activities at the CRCHUM (in French)